Genetic testing for chronic myeloid leukemia (CML) can tell doctors if someone has leukemia, what type they may have, and whether treatment is working. The tests look for atypical changes in certain ...
Study design and treatment strategy have been published previously. 3, 8 In brief, newly diagnosed CML patients in chronic phase (CP) were randomized into a 5-arm study comparing IM400 mg/day vs IM400 ...
Lindsay A. Rein, MD, reviews exciting data presented at this year’s ASH meeting, focusing on chronic myeloid leukemia (CML) and the recent approval of asciminib, a novel agent for first-, second-, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback